Published in:
01-08-2010 | Review
Rationale of using different biological therapies in rheumatoid arthritis
Authors:
Matthias Geyer, Ulf Müller-Ladner
Published in:
Arthritis Research & Therapy
|
Issue 4/2010
Login to get access
Abstract
Due to ongoing developments of novel agents in the field of biological pharmacotherapy, there are now more arrows available in clinicians' quivers for the treatment of rheumatic conditions. As a consequence, however, clear treatment strategies have to be defined in order to guarantee a qualitatively high and individually stage-adapted, state-of-the-art regimen for affected patients. This review summarizes recent evidence regarding the rationale of using different biological therapies to treat rheumatoid arthritis, the most common inflammatory joint disorder after activated osteoarthritis, and draws an actual picture of a possible standardized therapeutic algorithm without claiming exclusive appropriateness.